Comparison of the urinary excretion time courses of pyrene-1,6-dione, pyrene-1,8-dione and 1-hydroxypyrene in rats intravenously exposed to pyrene

References

• Bouchard M, Dodd C, Viau C. Improved procedure for the high-performance liquid chromatographic determination of monohydroxylated PAH metabolites in urine. Journal of Analytical Toxicology 1994; 18: 261–264
   PubMed Web of Science ®Google Scholar
• Bouchard M, Krishnan K, Viau C. Kinetics of tissue distribution and elimination of pyrene and 1-hydroxypyrene following intravenous administration of [14C]pyrene in rats. Toxicological Sciences 1998a; 46: 11–20
   PubMed Web of Science ®Google Scholar
• Bouchard M, Krishnan K, Viau C. Urinary excretion kinetics of 1-hydroxypyrene following intravenous administration of binary and ternary mixtures of polycyclic aromatic hydrocarbons in rat. Archives of Toxicology 1998b; 72: 475–482
   PubMed Web of Science ®Google Scholar
• Bouchard M, Viau C. Urinary excretion kinetics of pyrene and benzo(a)pyrene metabolites following intravenous administration of the parent compounds or the metabolites. Toxicology and Applied Pharmacology 1996; 139: 301–309
   PubMed Web of Science ®Google Scholar
• Bouchard M, Viau C. Urinary and biliary excretion kinetics of 1-hydroxypyrene following intravenous and oral administration of pyrene in rats. Toxicology 1998; 127: 69–84
   PubMed Web of Science ®Google Scholar
• Boyland E, Sims P. Metabolism of polycyclic compounds. The metabolism of pyrene in rats and rabbits. Biochemical Journal 1964; 90: 391–398
   PubMed Web of Science ®Google Scholar
• Buchet JP, Gennart F, Mercado-Calderon F, Delavognette JP, Cupers L, Lauwerys R. Evaluation of exposure to PAH in a coke production and graphite electrode manufacturing plant. British Journal of Industrial Medicine 1992; 49: 761–768
   PubMedGoogle Scholar
• Chénier V, Viau C. Mesure des variations de l'excrétion urinaire du 1-hydroxypyrène chez des individus sans exposition professionnelle aux hydrocarbures aromatiques polycycliques. Travail et Santé 1997; 13: S21–S24
   Google Scholar
• Chouinard S, Viau C. Reversibility of renal tubular dysfunction in streptozotocin-induced diabetes in the rat. Canadian Journal of Physiology and Pharmacology 1992; 70: 977–982
   PubMedGoogle Scholar
• Elovaara E, Vaananen V, Mikkola J. Simultaneous analysis of naphtols, phenanthrols, and 1-hydroxypyrene in urine as biomarkers of polycyclic aromatic hydrocarbon exposure: intraindividual variance in the urinary metabolite excretion profiles caused by intervention with beta-naphthoflavone induction in the rat. Archives of Toxicology 2003; 77: 183–193
   PubMed Web of Science ®Google Scholar
• Gerde P, Muggenburg BA, Scott GG, Lewis JL, Pyon KH, Dahl A. Local metabolism in lung airways increases the uncertainty of pyrene as a biomarker of polycyclic aromatic hydrocarbon exposure. Carcinogenesis 1998; 19: 101–108
   Google Scholar
• Hansen AM, Christensen JM, Sherson D. Estimation of reference values for urinary 1-hydroxypyrene and α-naphthol in Danish workers. Science of the Total Environment 1995; 163: 211–219
   PubMed Web of Science ®Google Scholar
• Hara K, Hanaoka T, Yamano Y, Itani T. Urinary 1-hydroxypyrene levels of garbage collectors with low-level exposure to polycyclic aromatic hydrocarbons. Science of the Total Environment 1997; 199: 159–164
   PubMed Web of Science ®Google Scholar
• Jacob J, Brune H, Gettbarn G, Grimmer D, Heinrich U, Mothashamipur E, Norpoth K, Pott F, Wenzel-Hartung R. Urinary and faecal excretion of pyrene and hydroxypyrene by rats after oral, intraperitoneal, intratracheal or intrapulmonary application. Cancer Letters 1989; 46: 15–20
   PubMed Web of Science ®Google Scholar
• Jacob J, Grimmer G, Raab G, Schmoldt A. The metabolism of pyrene by rat liver microsomes and the influence of various mono-oxygenase inducers. Xenobiotica 1982; 12: 45–53
   PubMed Web of Science ®Google Scholar
• Jongeneelen FJ, Anzion RBM, Henderson PT. Determination of hydroxylated metabolites of polycyclic aromatic hydrocarbons in urine. Journal of Chromatography 1987; 413: 227–232
   PubMed Web of Science ®Google Scholar
• Kang D, Rothman N, Cho S-H, Lim HS, Kwon H-J, Kim S-M, Schwartz B, Strickland PT. Association of exposure to polycyclic aromatic hydrocarbons (estimated from job category) with concentration of 1-hydroxypyrene glucuronide in urine from workers at a steel plant. Occupational and Environmental Medicine 1995; 52: 593–599
   PubMed Web of Science ®Google Scholar
• Keiming SD, Kirby KW, Morgan DP, Keiser JE, Hubert TD. Identification of 1-hydroxypyrene as a major metabolite of pyrene in pig urine. Xenobiotica 1983; 13: 415–420
   PubMedGoogle Scholar
• Petry T, Schmid P, Schlatter C. Exposure to polycyclic aromatic hydrocarbons (PAHs) in two different silicon carbide plants. Annals of Occupational Hygiene 1994; 38: 741–752
   Web of Science ®Google Scholar
• Roussel R, Allaire M, Friar RS. Atmospheric polycyclic aromatic hydrocarbons at a point source of emissions. Part A: Identification and determination of polycyclic aromatic compounds in airborne particulate matter near a horizontal stud Soderberg plant. Journal of the Air & Waste Management Association 1992; 42: 1609–1613
   Web of Science ®Google Scholar
• Ruzgyte A, Bouchard M, Viau C. Development of a high-performance liquid chromatographic method for the simultaneous determination of pyrene-1,6- and 1,8-dione in animal and human urine. Journal of Analytical Toxicology 2005; 29: 533–539
   PubMed Web of Science ®Google Scholar
• Tolos WP, Lowry LK, Shaw PB. The marker concept: 1-pyrenol as a biomarker for occupational exposure to polycyclic aromatic hydrocarbons. Biological monitoring of exposure to industrial chemicals, V Fiserova-Bergerova, M Ogata. American Conference of Governmental Industrial Hygienists, Cincinnati, OH 1990; 147–150
   Google Scholar
• US Environmental Protection Agency. (EPA) 2000. Methodology for deriving ambient water quality criteria for the protection of human health (2000). Technical Support Document, Vol. 1: Risk assessment. EPA-822-B-00-005. Washington, DC: Environmental Protection Office of Science and Technology, Agency United States Office of Water.
   Google Scholar
• Viau C, Bouchard M, Carrier G, Brunet R, Krishnan K. The toxicokinetics of pyrene and its metabolites in rats. Toxicological Letters 1999; 108: 201–208
   PubMed Web of Science ®Google Scholar
• Viau C, Carrier G, Vyskocil A, Dodd C. Urinary excretion kinetics of 1-hydroxypyrene in volunteers exposed to pyrene by the oral and dermal route. Science of the Total Environment 1995; 163: 179–186
   PubMed Web of Science ®Google Scholar
• Withey JR, Law FCP, Endrenyi L. Pharmacokinetics and bioavailability of pyrene in the rat. Journal of Toxicology and Environmental Health 1991; 32: 429–447
   PubMed Web of Science ®Google Scholar
• Zhao Z-H, Quan W-Y, Tian D-H. Urinary 1-hydroxypyrene as an indicator of human exposure to ambient polycyclic aromatic hydrocarbons in a coal-burning environment. Science of the Total Environment 1990; 92: 145–154
   PubMed Web of Science ®Google Scholar